Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-042885

BIOLASE, INC · BIOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Harold C Flynn Jr.
Officer — President and CEO · Director
Period of report
Jun 30, 2017
Accepted (ET)
Jul 3, 2017 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 30, 2017C30,700$1.24A66,100IBy Trust
Common Stockholding———96,720D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series D Participating Convertible Preferred StockF3,F5,F6,F4$1.24Jun 30, 2017C307DJun 30, 2017—Common Stock30,7000I

Explanation of responses